Swedish Orphan B
Stock
Stock
ISIN: SE0000872095
Ticker: SOBI
SE0000872095
SOBI
Price
Price
CHART BY
Frequently asked questions
What is Swedish Orphan B's market capitalization?
The market capitalization of Swedish Orphan B is SEK 153.56B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Swedish Orphan B's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Swedish Orphan B is 167.11. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Swedish Orphan B?
Swedish Orphan B's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $2.657. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Swedish Orphan B's stock?
Currently, 13 analysts cover Swedish Orphan B's stock, with a consensus target price of SEK 485.83. Analyst ratings provide insights into the stock's expected performance.
What is Swedish Orphan B's revenue over the trailing twelve months?
Over the trailing twelve months, Swedish Orphan B reported a revenue of SEK 28.96B.
What is the EBITDA for Swedish Orphan B?
Swedish Orphan B's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is SEK 18.54B. EBITDA measures the company's overall financial performance.
What is the free cash flow of Swedish Orphan B?
Swedish Orphan B has a free cash flow of SEK 7.36B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Swedish Orphan B have, and what sector and industry does it belong to?
Swedish Orphan B employs approximately 1,888 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
What is the free float of Swedish Orphan B's shares?
The free float of Swedish Orphan B is 180.59M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- SEK 153.56B
- EPS (TTM)
- $2.657
- Free Float
- 180.59M
- P/E ratio (TTM)
- 167.11
- Revenue (TTM)
- SEK 28.96B
- EBITDA (TTM)
- SEK 18.54B
- Free Cashflow (TTM)
- SEK 7.36B
Pricing
- 1D span
- $47.00$48.34
- 52W span
- $27.06$48.49
Analyst Ratings
The price target is SEK 485.83 and the stock is covered by 13 analysts.
Buy
10
Hold
3
Sell
0
Information
Swedish Orphan Biovitrum AB engages in the research, development, manufacture, and sale of pharmaceuticals. It operates through the Haematology, Immunology, and Specialty Care segments. The Haemotology segment focuses on haemophilia medicines Elocta and Alprolix. The immunology segment offers treatment for serious, disabling, and life-threatening diseases. The Specialty Care segment specializes in the treatment of genetic and metabolic diseases. The company was founded in 2001 and is headquartered in Solna, Sweden.
- Employees
- 1,888
- Industries
- Major Pharmaceuticals
- Sector
- Health Care
Identifier
- ISIN
- SE0000872095
- Primary Ticker
- SOBI
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet